Premium Information is available for this item - Upgrade for $1 a day

6505-01-462-5543

Usp Dextrose Injection

6505014625543 014625543 2B0062Q

6505-01-462-5543 DEXTROSE INJECTION,USP 6505014625543 014625543

Managed by United States
NSN Created on 8 Feb 1999
Data Last Changed
January 2023
NATO Update Count
4
NATO Data Quality
6505-01-462-5543 DEXTROSE INJECTION,USP 6505014625543 014625543 1/1
NSN 6505-01-462-5543 (Generic Image) 1/1

6505-01-462-5543 Stock and Availability Marketplace 6505-01-462-5543

Need Help?
Request a Quotation from participating marketplace vendors
eBay Updated Every Day
6505-01-462-5543 RQST NE eBay
eBay Updated Every Day
6505-01-462-5543 RQST eBay
Amazon Updated Every Day
6505-01-462-5543 RQST NE Amazon

6505-01-462-5543 Related Documents Related Documents 6505-01-462-5543 5+ Documents (More...)

( More... ) https//www.nsnlookup.com /cage Baxter Healthcare Corp (CAGE Code 01KW6) Feb 1999 6505-01-462-5543
5557 https//www.nsnlookup.com /cage Baxter Healthcare Corporation (CAGE Code 1G026) Feb 1999 6505-01-462-5543
1997 6515-01-462-5464 Intravenous Injection Set 2C6425RNCC: 5 | RNVC: 9 | DAC: 4 8 Feb 1999 6505-01-462-5543
1999 6515-01-462-5464 Intravenous Injection Set 2C6425RNCC: 3 | RNVC: 2 | DAC: 4 8 Feb 1999 6505-01-462-5543
Account Upgrade 6505-01-462-1912Usp Dextrose Injection6505014621912 014621912 99-0402 NDC00338-0017-02 2B0062Q
0402 89875 - Defense Logistics Agency (Active) Incomplete Secondary Reference RNCC 5 RNVC 1 DAC 4 2B0062Q
0402 Upgrade 6505-01-462-1912Usp Dextrose Injection6505014621912 014621912 99-0402 NDC00338-0017-02 2B0062Q

6505-01-462-5543 Demil Restrictions 6505-01-462-5543

DEMIL: A | DEMILI: 1 | CRITICALITY: X | HMIC: P | PMIC: A | EDC: | ADPEC:

6505-01-462-5543 is a Usp Dextrose Injection that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. This item does not contain a precious metal.

6505-01-462-5543 HTS and ScheduleB Import and Export 6505-01-462-5543

6505-01-462-5543 End Users End Users 6505-01-462-5543

MOE Rule:
V540
Effective Date:
1 Feb 1999

6505-01-462-5543 Manufacturers Approved Sources 6505-01-462-5543

6505-01-462-5543 Technical Data Datasheet 6505-01-462-5543

Characteristic
Specifications
FIIG
A45100
Active Medicament Medicinal Strength [AKJA]
5.000 Percentage, W/V Dextrose Active Ingredient
Pharmaceutical Vehicle Type [AKJQ]
Aqueous
Primary Container Type [CQCT]
Bag, Plastic
Primary Container Content Quantity [CRLK]
250.000 Milliliters
Total Primary Container Quantity [CSCW]
36
Features Provided [CBBL]
Sterile
Special Features [FEAT]
With Overpouch As Water Vapor Barrier; Viaflex Container

6505-01-462-5543 Related Items NATO Stock Numbers Related to 6505-01-462-5543

6505-01-462-5543 Freight Data Freight Information 6505-01-462-5543

6505-01-462-5543 has freight characteristics.. 6505-01-462-5543 has a variance between NMFC and UFC when transported by rail and the description should be consulted.